Back to Agenda
Part 2: Signaling Approaches/Methods
Session Chair(s)
James Buchanan, PHARMD
President
Covilance LLC, United States
- Analysis of Post-Marketing Data
- Comparison to Clinical Trial Data
- Signaling Examples
- Case Studies
Have an account?
Already a DIA Member? Sign in. Not a member? Join.
Sign in
Not a Member?
Online
Jul 25, 2016 12:00 PM - Jul 28, 2016 1:30 PM